Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age
- 9 July 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (32), 4278-4283
- https://doi.org/10.1016/j.vaccine.2009.05.023
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months OldPublished by American Medical Association (AMA) ,2006
- The Underrecognized Burden of Influenza in Young ChildrenNew England Journal of Medicine, 2006
- Data Mining in the US using the Vaccine Adverse Event Reporting SystemDrug Safety, 2006
- Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990–2003Pediatrics, 2005
- Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccinationThe Pediatric Infectious Disease Journal, 2004
- Illness Among Schoolchildren During Influenza SeasonArchives of Pediatrics & Adolescent Medicine, 2002
- Burden of Interpandemic Influenza in Children Younger than 5 Years: A 25‐Year Prospective StudyThe Journal of Infectious Diseases, 2002
- The burden of influenza illness in children with asthma and other chronic medical conditionsThe Journal of Pediatrics, 2000
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenNew England Journal of Medicine, 2000
- Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young childrenVaccine, 1993